Plant molecular farming: Opportunities and challenges

Critical Reviews in Biotechnology

Volumn 28, Issue 3, 2008, Pages 153-172

  Basaran, Pervin ^a,b   Rodriguez Cerezo, Emilio ^a  

^a JOINT RESEARCH CENTRE   (Italy)

^b Department of Food Engineering ^*  (Turkey)

Author keywords

Genetically modified organisms (GMOs); Transgenic plants

Indexed keywords

ANIMAL CELL CULTURE; ENVIRONMENTAL IMPACT; PLANT CELL CULTURE;

ECONOMIC IMPLICATIONS; EXPRESSION SYSTEMS; GENETICALLY MODIFIED ORGANISMS (GMOS); IN PLANTS; MICROBIAL; MOLECULAR FARMINGS; PLANT CELLS; PRODUCTION COSTS.; SOCIOECONOMIC; TECHNICAL FEASIBILITIES; TRANSGENIC PLANTS;

CELL CULTURE;

ALPHA GALACTOSIDASE; ALPHA INTERFERON; ANTIBODY; APOLIPOPROTEIN A1; APROLIZEAN; APROTININ; AVICIDIN; AVIDIN; CARORX; CYTOKINE; FIBRINOLYTIC AGENT; GASTRIC LIPASE; GLUCOSYLCERAMIDASE; HEPATITIS B SURFACE ANTIGEN; INDUSTRIAL ENZYME; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LACTOFERRIN; MONOCLONAL ANTIBODY; NEWCASTLE DISEASE VACCINE; NUTRACEUTICAL; TRIACYLGLYCEROL LIPASE; TYPZEAN; UNCLASSIFIED DRUG; VACCINE; VIBRIO CHOLERAE VACCINE; VIRUS VACCINE;

AGRICULTURAL WORKER; ARABIDOPSIS; DNA MODIFICATION; ECONOMIC ASPECT; ENVIRONMENTAL IMPACT; FEASIBILITY STUDY; IMMUNOTHERAPY; NONHUMAN; PLANT; PLANT BIOTECHNOLOGY; PLANT CELL CULTURE; PLANT PRODUCT; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; TRANSGENIC PLANT; VIBRIO CHOLERAE;

BIOTECHNOLOGY; CELLS, CULTURED; GENETIC ENHANCEMENT; PLANT EXTRACTS; PLANT PROTEINS; PLANTS, GENETICALLY MODIFIED; PROTEIN ENGINEERING;

ANIMALIA;

EID: 54349106722     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.1080/07388550802046624     Document Type: Review

References (124)

1. Ammann, K. 2004. The role of science and discourse in the application of the precautionary approach. In: Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 291-301. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
2. Arcand, F., and Arnison, P. 2004, April. Development of Novel Protein-Production Systems and Economic Opportunities and Regulatory Challenges for Canada. Available at: www.plantpharma.org/documents/NPPS 040412.pdf. Accessed March 31, 2008.
3. Argevin, F., Klein, E. K., Choimet, C., Gauffreteau, A., Lavigne, C., Messéan, A., and Meynard, J. M. 2008. Modelling impacts of cropping systems and climate on maize cross-pollination in agricultural landscapes: The MAPOD model. Eur. J. Agronomy 28: 471-484.
4. Bakker, H., Bardor, M., Molthoff, J. W., Gomord, V., Elbers, I., Stevens, L. H., Jordi, W., Lommen, A., Faye, L., and Lerouge, P. 2001. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. USA 98: 2899-2904.
5. Bardor, M., Cabrera, G., Rudd, P. M., Dwek, R. A., Cremata, J. A., and Lerouge, P. 2006. Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals. Curr. Opin. Struct. Biol. 16: 576-583.
6. Barta, A., Sommengruber, K., Thompson, D., Hartmuth, K., Matzke, M., and Matzke, A. 1986. The expression of a napoline synthase human growth hormone chimeric gene in transformed tobacco and sunflower callus tissue. Plant Mol. Biol. 6: 347-357.
7. Basaran, P., and Rodríguez-Cerezo, E. 2008. An assessment of emerging molecular farming activities based on patent analysis (2002-2006). Biotech. Bioprocess Engineer. (In press)
8. Bernatchez, S., Gilbert, M., Blanchard, M. C., Karwaski, M. F., Li, L., DeFrees, S., and Wakarchuk, W. W. 2007. Variants of the β1,3- Galactosyltransferase CgtB from the bacterium Campylobacter jejuni have distinct acceptor specificities. Glycobiology 17: 1333-1343.
9. Bischoff, F., 2004. A top-down view of molecular farming from the pharmaceutical industry: requirements ad expectations. In: Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 267-287. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
10. Bock, R. 2001. Transgenic chloroplasts in basic research and plant biotechnology. J. Mol. Biol. 312: 425-438.
11. Bock, R. 2007. Plastid biotechnology: prospects for herbicide and insect resistance, metabolic engineering and molecular farming. Curr. Opin. Biotechnol. 18: 100-106.
12. Bogorad, L. 2000. Engineering chloroplasts: an alternative site for foreign genes, proteins, reactions and products. Tibtech. 18: 257-263.
13. Bosch, D., Small, J., and Krebbers, E. 1994. A trout growth hormone is expressed, correctly folded and partially glycosylated in the leaves but not the seeds of transgenic plants. Transgenic Res. 3: 304-310.
14. Brandle, J. 2004. The field evaluated of transgenic crops engineered to produce recombinant proteins. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 69-76. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
15. Brodzik, R., Bandurska, K., Deka, D., Golovkin, M., and Koprowski, H. 2005. Advances in alfalfa mosaic virus-mediated expression of anthrax antigen in planta. Biochem. Biophys. Res. Commun. 338: 717-722.
16. Center for Infectious Diseases and Vaccinology. 2006. ProVacs. Available at: www.biodesign.asu.edu/centers/idv/projects/provacs. Accessed March 31, 2008.
17. Chargelegue, N. D., Drake, P. M. W., Obregon, P., and Ma, J. C. K. 2005. Production of secretory IgA in transgenic plants. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 159-169. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
18. Chargelegue, N. D., van Dolleweerd, C. J., Drake, P. M., and Ma, J. C. K. 2000. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Trangenic Res. 9: 187-194.
19. Chong, D. K. X., Roberts, W., Arakawa, T., Illes, K., Bagi, G., Slattery, C. W., and Langridge, W. H. R. 1997. Expression of the human milk protein beta-casein in transgenic potato plants. Transgenic Res. 6: 289-296.
20. Christou, P., Stoger, E., and Twyman, R. M. 2004. Monocot expression systems for Molecular Farming. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 55-67. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
21. Chu, L., and Robinson, D. K. 2001. Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol. 12: 180-187.
22. Commandeur, U., Twyman, R. M., and Fischer, R. 2003. The biosafety of molecular farming in plants. AgBiotechNet 30: 109-112.
23. Cramer, C. L., Boothe, J. G., and Oishi, K. K. 1999. Transgenic plants for therapeutic proteins: linking upstream and downstream strategies. Curr. Top. Microbiol. Immunol. 240: 95-118.
24. Daniell, H. 1999. GM crops: public perception and scientific solutions. Trends Plant Sci. 4: 467-469.
25. Daniell, H. 2002. Molecular strategies for gene containment in transgenic crops. Nat. Biotechnol. 20: 581-586.
26. Daniell, H., Carmona-Sanchez, O., and Burns, B. E. 2004. Chloroplast derived antibodies, biopharmaceuticals and edible vaccines. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins.113-133. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
27. Daniell, H., Khan, M. S., and Allison, L. 2002. Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 7: 84-91.
28. Daniell, H., Streatfield, S. J., and Wycoff, K. 2001. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6: 219-226.
29. Datar, R. V., Cartwright, T., and Rosen, C. G. 1993. Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator. Bio/technology, 11: 349-357.
30. Drossard, J. 2004. Downstream processing of plant-derived recombinant therapeutic proteins. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 217-230. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
31. Eastham, K., and Sweet, J. 2002. Genetically Modified Organisms (GMOs): The Significance of Gene flow Through Pollen Transfer. European Environment Agency, Environment Issue Report No. 28.
32. Einsiedel, E. F., and Medlock, J. 2005. A public consultation on plant molecular farming. AgBioForum 8: 26-32.
33. Fiedler, U., Phillips, J., Artsaenko, O., and Conrad, U. 1997. Optimization of scFv antibody production in transgenic plants. Immunotechnology 3: 205-216.
34. Fischer, R., and Stoger, E. 2004. Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7: 152-158.
35. Fischer, R., Stoger, E., Schillberg, S., Christou, P., and Twyman, R. M. 2004. Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7: 152-158.
36. Freese, B. 2002, July. Manufacturing Drugs and Chemical Crops: Biopharming Poses New Threats to Consumers, Farmers, Food Companies and the Environment. Available at: www.foe.org/ camps/comm/safefood/biopharm/ BIOPHARM REPORT.pdf. Accessed March 31, 2008.
37. Frigerio, L., Vine, N. D., Pedrazzini, E., Hein, M. B., Wang, F., Ma, J. C. K., and Vitale, A. 2000. Assembly, secretion, and vacuolar delivery of a hybrid immunoglobulin in plants. Plant Physiol. 123: 1483-1494.
38. Fu, X., Duc, L. T., Fontana, S., Bong, B. B., Tinjuangjun, P., Sudhakar, D., Twyman, R. M., Christou, P., and Kohli, A. 2000. Linear transgene constructs lacking vector backbone sequences generate low-copy-number transgenic plants with simple integration patterns. Transgenic Res. 9: 11-19.
39. Gasdaska, J. R., Spencer, D., and Dickey, L. 2003. Advantages therapeutic protein production in the aquatic plant Lemma. Bioprocess J. 2: 49-56.
40. Gleba, Y., Klimyuk, V., and Marillonnet, S. 2005. Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine, 23: 2042-2048.
41. Gleba, Y., Klimyuk, V., and Marillonnet, S. 2007. Viral vectors for the expression of proteins in plants . Curr. Opin. Biotechnol. 18: 134-141.
42. Gomord, V., Chamberlain, P., Jefferis, R., and Faye, L. 2005. Biopharmaceutical production un plants: problems, solutions, and opportunities. Trends Biotechnol. 23: 559-565.
43. Gomord, V., and Faye, L. 2004. Posttranslational modification of therapeutic proteins in plants. Curr. Opin. Plant Biol. 7: 171-181.
44. Gomord V., Fitchette, A. C., and Lerouge, P. 2004. Glycosylation of plant-made pharmaceuticals. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 233-250. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
45. Gressel, J. 2000. Molecular Biology of weed control. Transgenic Res. 9: 355-382.
46. Guruatma, K., Mason, H. S., and Arntzen, C. J. 2004. Plant-derived vaccines: progress and constraints. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 135-155. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
47. Gruber, V., Berna, P., Arnaud, T., Bournat, P., Clément, C., Mison, D., Olagnier, B., Philippe, L., Theisen, M., Baudino, S., Bénicourt, C., Cudrey, C., Bloës, C., Duchateau, N., Dufour, S., Gueguen, C., Jacquet, S., Ollivo, C., Poncetta, C., Zorn, N., Ludevid, D., Van Dorsselaer, A., Verger, R., Doherty, A., Mérot, B., and Danzin, C. 2001. Large-scale production of a therapeutic protein in transgenic tobacco plants: effect of subcellular targeting on quality of a recombinant dog gastric lipase. Mol. Breeding 7: 329-340.
48. Hall, C., and Moran, D. 2006. Investigating GM risk perceptions: a survey of anti-GM and environmental campaign group members. J. Rural Studies. 22: 29-37.
49. Hood, E. E. 2002. From green plants to industrial enzymes. Enzyme Microb. Technol. 30: 279-283.
50. Hood, E. E., and Jilka, J. M. 1999. Plant-based production of xenogenic proteins. Curr. Opin. Biotechnol. 10: 382-386.
51. Hood, E. E., Woodard, S. L., and Horn, M. E. 2002. Antibody manufacturing in transgenic plants: myths and realities. Curr. Opin. Biotechnol. 13: 630-635.
52. Horn, M. E., Woodard, S. L., and Howard, J. A. 2004. Plant molecular farming: systems and products. Plant Cell Reports 22, 711-720.
53. Howard J. A., and Hood, E. 2005. Bio-industrial and biopharmaceutical products produced in plants. Advances in Agronomy 85: 91-123.
54. Howard J. A., and Hood, E. E. 1998. Commercial production of proteases in plants. US Patent 6,087,558.
55. Huang, Z., Santi, L., Lepore, K. Kilbourne, J., Arntzen, C. J., and Mason, H. S. 2006. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 24: 2506-2513.
56. Huot, M.-F. 2003, June. Plant Molecular Farming: Issues and Challengesfor Canadian Regulators. Consumers Affairs Office, Industry Canada. Available at: www.option-consommateurs.org/documents/ 1130 principal/fr/File/rapports/foods/molecular farming oc0603. pdf. Accessed March 31, 2008.
57. Inaba, Y., Zhong, W. Q., Zhang, X.-H., and Widholm, J. M. 2007. Specificity of expression of the GUS reporter gene (uidA) driven by the tobacco ASA2 promoter in soybean plants and tissue cultures. J. Plant Physiol. 164: 824-834.
58. Jiang, L. W., and Sun, S. S. M. 2002. Membrane anchors for vacuolar targeting: application in plant bioreactors. Trends Biotechnol. 20: 99-102.
59. Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., and Legocki, A. B. 1999. A plant-derived edible vaccine against hepatitis B virus. FASEB Journal 13: 1796-1799.
60. Karasev, A. V., Foulke, S., Wellens, C., Rich, A., Shon, K. J., Zwierzynski, I., Hone, D. Koprowski, H., and Reitz, M. 2005. Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine 23: 1875-1880.
61. Khalsa, G., Mason, H. S., and Arntzen, C. J. 2004. Plant-derived vaccines: progress and constrains. In Molecular Farming: Plant-made Pharmaceuticals and Technical Proteins, 135-158. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
62. Kirk, D. D., and McIntosh, K. 2005. Social acceptance of plant made vaccines: indications from a public survey. AgBioForum 8: 228-234.
63. Kling, J. 1996. Could transgenic supercrops one day breed superweeds? Science 274: 180-181.
64. Koprowski, H. 2005. Vaccines and sera through plant biotechnology, Vaccine. 23: 1757-1763.
65. Kusnadi, A. R., Hood, E. E., Witcher, D. R., Howard, J. A., and Nikolov, Z. L. 1998. Production and purification of two recombinant proteins from transgenic corn. Biotechnol. Prog. 14: 149-155.
66. Lamphear, B. J., Streatfield, S. J., Jilka, J. M., Brooks, C. A., Barker, D. K., Turner, D. D., Delaney, D. E., Garcia, M., Wiggins, B., Woodard, S. L., Hood, E. E., Tizard, I. R., Lawhorn, B., and Howard, J. A. 2002. Delivery of subunit vaccines in maize seed. J. Control. Release 85: 169-180.
67. Lee, R. W. H., Pool, A. N., Ziauddin, A., Lo, R. Y. C., Shewen P. E., and Strommer, J. N. 2003. Edible vaccine development: stability of Mannheimia haemolytica A1 leukotoxin 50 during post-harvest processing and storage of field-grown transgenic white clover Mol. Breeding 11: 259-266.
68. Lutz, K. A., and Maliga, P. 2007. Construction of marker-free transplastomic plants. Curr. Opin. Biotechnol. 18: 107-114.
69. Ma, J. K. C., Chikwamba, R., Sparrow, P., Fischer, R., Manohey, R., and Twyman, R. M. 2005. Plant-derived pharmaceutical -the road forward. Trends Plant Sci. 10: 580-585.
70. Ma, J. K. C., Hiatt, A., Hein, M., Vine, N. D., Wang, F., Stabila, P., van Dolleweerd, C., Mostov, K., and Lehner, T. 1995. Generation and assembly of secretory antibodies in plants. Science, 268: 716-719.
71. Ma, J. K. C., Hikmat, B. Y., Wycoff, K., Vine, N. D., Chargelegue, D., Yu, L., Hein, M. B., and Lehner, T. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4: 601-606.
72. Ma, J. K. C., Lehrner, T., Stabila, P., Fux, C. I., and Hiatt, A. 1994. Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur. J. Immunol. 24: 131-138.
73. Maliga, P. 2002. Engineering the plastid genome of higher plants. Curr. Opin. Plant Biol. 5: 164-172.
74. Maliga, P. 2004. Plastid transformation in higher plants. Annu. Rev. Plant Biol. 55: 289-313.
75. Maliga, P., and Graham, I. 2004. Molecular farming and metabolic engineering promises a new generation of transgenic crops. Curr. Opin. Plant Biol. 7: 149-151.
76. Mascia, P. N., and Flavell, R. B. 2004. Safe and acceptable strategies for producing foreign molecules in plants. Curr. Opin. Plant Biol. 7: 189-195.
77. Mayfield, S. P., Franklin, S. E., and Lerner, R. A. 2003. Expression and assembly of a fully active antibody in algae. Proc. Natl Aca. Sci. USA 100: 438-442.
78. McCormick, A. A., Kumagai, M. H., Hanley, K., Turpen, T. H., Hakim, I., Grill, L. K., Tuse, D., Levy, S., and Levy, R. 1999. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc. Natl Acad. Sci. USA 96: 703-708.
79. McCormick A. A., Reinl, S. J., Cameron, T. I., Vojdani, F., Fronfield, M., Levy, R., and Tuse, D. I. 2003. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. Immunol Methods 278: 95-104.
80. Menassa, R., Nguyen, V., Jevnikar, A. N., and Brandle, J. E. 2001. A self-contained system for the field production of plant recombinant human interleukin-10. Mol. Breeding 8: 177-185.
81. Mercer, D. K., Scott, K. P., Melville, C. M., Glover, L. A., and Flint, H. J. 2001. Transformation of an oral bacterium via chromosomal integration of free DNA in the presence of human saliva. FEMS Microbiol. Lett. 200: 163-167.
82. Meurer, H. 2004, March. Genetic engineering. Alive Maga-zine #257. Available at: www.alive.com/1743a5a2.php?subject bread cramb=635%20(2006). Accessed March 31, 2008.
83. Miele, L. 1997. Plants as bioreactors for biopharmaceuticals: regulatory considerations. Trends Biotechnol. 15: 45-50.
84. Mikkelsen, T. R., Jensen, J., and Jorgensen, R. B. 1996. Inheritance of oilseed rape (Brassica napus) RAPD markers in a backcross progeny with Brassica campestris. Theor. Appl. Genet. 92: 492-497.
85. Nap, J.-P., Metz, P. L. J., Escaler, M., and Conner, A. J. 2003. The release of genetically modified crops into the environment. Part I. Overview of current status and regulations. Plant J. 33: 1-18.
86. Nevitt, J., Norton, G., Mills, B., Jones, M. E., Ellerbrock, M., and Reaves, D. 2003, April. Participatory assessment of social and economic effects of using transgenic tobacco to produce pharmaceuticals. Working Paper No. 2003-1. Virginia Tech, Blacksburg. Available at: www.agecon. vt.edu/biotechimpact/tobacco/WP20031.pdf. Accessed March 31, 2008.
87. Nielsen, K. M., Bones, A., Smalla, K., and van Elsas J. D. 1998. Horizontal gene transfer from transgenic plants to terrestrial bacteria - a rare event? FEMS Microbiol. Rev. 22: 79-103.
88. Paez, R., Cremata, J. A., Enriquez, G., Mendoza, O., Ortega, M., and Borroto, C. 2005. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine 23: 1833-1837.
89. Pan, L., Zhang, Y., Wang, Y., Wang, B., Wang, W., Fang, Y., Jiang, S., Lv, J., Wang, W., Sun Y., and Xie, Q. 2008. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1 - 2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs. Vet. Immunol. Immunopathol. 121: 83-90.
90. Pezzotti, M., Schillberg, S., Sparrow, P., Stoger, E., and Twyman, R. M. 2005. Molecular Farming for new drugs and vaccines. EMBO Reports 6: 593-599.
91. Pogue, G. P., Lindbo, J. A., Garger, S. J., and Fitzmaurice, W. P. 2002. Making an ally from an enemy: plant virology and the new agriculture, Annu. Rev. Phytopathol. 40: 45-74.
92. Poirier, Y., Dennis, D. E., Klomparens, K., and Somerville, C. 1992. Polyhydroxybutyrate, a biodegradable thermoplastic, produced in transgenic plants. Science 256: 520-523.
93. Pujol, M., Ramírez, N. I., Ayala, M., Gavilondo, J. V., Valdés, R., Rodriguez M., Brito, J., Padilla, S., Gomez, L., Reyes, B., Peral, R., Perez, M., Marcelo, J. L., Mila, L., Sanchez, R. F., Rolando, P., Cremata, J. A., Enriquez, G., Mendoza, O., Ortega, M, and Borroto, C. 2005. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine 23: 1833-1837.
94. Roggero, P., Ciuffo, M., Benvenuto, E., and Franconi, R. 2001. The expression of a single-chain Fv antibody fragment in different plant hosts and tissues by using Potato virus X as a vector. Protein Expr. Purif. 22: 70-74.
95. Saint-Jore-Dupas, C., Faye L., and Gomord, V. 2007. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol. 25: 317-323.
96. Scheller, J., and Conrad, U. 2004. Production of silk proteins in transgenic tobacco. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 171-181. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
97. Scheller, J., Henggeler, D, Viviani, A., and U. Conrad. 2004. Purification of spider silk-elastin from transgenic plants and application for human chondrocyte proliferation. Transgenic Res. 13:51-57.
98. Schillberg, S., Twyman, R. M., and Fischer, R. 2005. Opportunities for recombinant antigen and antibody expression in transgenic plantstechnology assessment. Vaccine 23: 1764-1769.
99. Schluter, K., Futterer, J., and Potrykus, I. 1995. Horizontal genetransfer from a transgenic potato line to a bacterial pathogen (Erwiniachrysanthem) occurs, if at all, at an extremely low-frequency. Bio/Technology 13: 1094-1098.
100. Sedjo, R. A. 2005. Will Developing Countries be the Early Adopters of Genetically Engineered Forests? AgBioForum, 8: 205-212.
101. Shadwick, F. S., and Doran P. M. 2004. Foreign protein expression using plant cell suspension and hairy root cultures. In Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins, 13-36. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
102. Sharp, J. M., and Doran, P. M. 2001. Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures. Biotechnol. Prog. 17: 979-992.
103. Smith, N., Kilpatrick, J. B., and Whitelam. G. C. 2001. Superfluous transgene integration in plants. Crit. Rev. Plant Sci. 20: 215-249
104. Smyth, S., and Philips, P. W. B. 2002. Product Differentiation Alternatives: Identity Preservation, Segregation, and Traceability. AgBioForum 5: 30-42.
105. Spök, A. 2007. Molecular Farming on the rise - GMO regulators still walking a tightrope. Trends in Biotech. 25: 74-82.
106. Stoger, E., Ma, J. K. C., Fischer, R., and Christou, P. 2005. Sowing the seeds of success: pharmaceutical proteins from plants. Curr. Opin. Biotechnol. 16: 167-173.
107. Streatfield, S. J. 2006. Mucosal immunization using recombinant plant-based oral vaccines. Methods 38: 150-157.
108. Tackaberry, E. S., Prior, F., Bell, M., Tocchi, M., Porter, S., Mehic, L., Ganz, P. R., Sardana, R., Altosaar, I., and Dudani, A. 2003. Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Genome 46: 521-526.
109. Tacket, C. O. 2005. Plant-derived vaccines against diarrheal diseases. Vaccine 23: 1866-1869.
110. Tacket, C. O., Mason, H. S., Losonsky, G., Estes, M. K., Levine, M. M., and Arntzen, C. J. 2000. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182: 302-305.
111. Taticek, R. A., Lee, C. W. T., and Shukler, M. L. 1994. Large-scale insect and plant cell culture. Curr. Opin. Biotechnol. 5: 165-174.
112. Tregoning, J. S., Nixon, P., Kuroda, H., Svab, Z., Clare, S., Bowe, F., Fairweather, N., Ytterberg, J., van Wijk, K. J., Dougan, G., and Maliga, P. 2003. Expression of tetanus toxin fragment C in tobacco chloroplasts, Nucleic Acids Res. 31: 1174-1179.
113. Twyman, R. M. 2004. Host plants, systems and expression strategies for Molecular Farming. In Molecular Farming: Plant-made Pharmaceuticals and Technical Proteins, 191-216. Fischer, R., and Schillberg, S., eds., Wiley-VCH, Weinheim, Germany.
114. Twyman, R. M., Stoger, E., Schillberg, S., Chrishou, P., and Fischer. R. 2003. Molecular Farming in plants: host systems and expression technology. Trends Biotechnol. 21: 570-578.
115. Usharani, K. S., Periasamy, M., and Malathi, V. G. 2006. Studies on the activity of a bidirectional promoter of Mungbean yellow mosaic India virus by agroinfiltration. Virus Res. 119: 154-162.
116. van der Laan, J. W., Minor, P., Mahoney, R., Arntzen, C., Shin, J., and Wood, D. 2006. WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24-25 January 2005. Vaccine 24: 4271-4278.
117. Walsh, G. 2003. Biopharmaceutical Benchmarks, Nature Biotechnol. 21: 865-870.
118. Wang, L., Webster D. E., Campbell, A. E., Dry, I. B., Wesselingh, S. L., and Coppel, R. L. 2008. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants. Int. J. Parasitol. 38: 103-110.
119. Webster, D. E., Smith, S. D., Pickering, R. J., Strugnell, R. A., Dry, I. B., and Wesselingh, S. L. 2006. Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination. Vaccine 24: 3538-3544.
120. Wieland, W. H., Lammers, A., Schots, A., and Orzaez, D. V. 2006. Plant expression of chicken secretory antibodies derived from combinatorial libraries. J. Biotechnol. 112, 382-391.
121. Wilde, C. D., Peeters, K., Jacobs, A., Peck, I., and Depicker, A. 2002. Expression of antibodies and Fab fragments in transgenic potato plants: A case study for bulk production in crop plants. Mol. Breed. 9: 271-282.
122. Woodard, S. L., Mayor, J. M., Bailey, M. R., Barker, D. K., Love, R. T., Lane, J. R., Delaney, D. E., McComas-Wagner, J. M., Mallubhotla, H. D., Hood, E. E., Dangott, L. J.,Tichy, S. E., and Howard J. A. 2003. Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol. Appl. Biochem. 38: 123-130.
123. Yu, J., and Langridge, W. 2003. Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res. 12: 163-169.
124. Yusibov, V., Hooper, D. C., Spitsin, S. V., Fleysh, N., Kean, R. B., Mikheeva, T., Deka, D., Karasev, A., Cox, S., Randall, J., and Koprowski, H. 2002. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine. 20: 3155-3164.